TIVC 8-K: SEC filing

Valion Bio, Inc.

Filed with the SEC on · accession 0001683168-26-008352

TIVC filed a 8-K (current report) with the SEC on Nov 5, 2026. Valion Bio, Inc. filed a Form 8-K cover page with the SEC on November 5, 2026, for the period ending October 31, 2026.

Summary of the filing

Valion Bio, Inc. filed a Form 8-K cover page with the SEC on November 5, 2026, for the period ending October 31, 2026. The filing contains only cover page XBRL data and no substantive disclosure of a corporate event.

Key details

RegistrantValion Bio, Inc.

✦ Ask GOAX AI about this filing — what it means for TIVC, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for TIVC?

Click here

Frequently asked questions

What did TIVC file with the SEC on Nov 5, 2026?

TIVC filed a 8-K (SEC filing). Valion Bio, Inc. filed a Form 8-K cover page with the SEC on November 5, 2026, for the period ending October 31, 2026. The filing contains only cover page XBRL data and no substantive disclosure of a corporate event.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Other TIVC SEC filings

Get alerts when TIVC files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days